Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol for Adjustment Disorders from Romantic Betrayals
NCT03151681Phase 3Completed
- Sponsor
- Douglas Mental Health University Institute
- Start
- Nov 2015
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of propranolol in adjustment disorder (AD) (3 arms), sponsored by Douglas Mental Health University Institute. Primary endpoint: Impact of Events Scale-Revised. Started Nov 2015; status: completed.
02
Drugs
propranolol
03
Conditions
adjustment disorder (AD)
Beyond the preview
Go deeper on NCT03151681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03151681.